MED
Medifast Stock Analysis
AI Rating
- Quality9/10
- Growth↓ 1/10
- Value↓ 3/10
MED Growth
- Revenue Y/Y↓ -36.62%
- EPS Y/Y↓ -180.00%
- FCF Y/Y↓ -110.92%
MED Profitability
- Gross margin ↑ 70.10%
- EPS margin↓ -5.80%
- ROIC 5Y↓ 44.72%
MED Risk
- Debt / Equity↓ 0.1
- Debt / FCF↓ 0.0
- Interest coverage↓ NA
Medifast stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.